Stabilized host-parasite-hyperparasite cycle with <i>K</i>_<i>M</i> in μM range. gan Magnus Pirovino (14845999)

Pynciau:

It is the composite label for supplementary data that comprise three data sets, i) S1 Definition of terms and notations, ii) the main file S1 Supporting Information describing the... gan Magnus Pirovino (14845999)

Pynciau:

Autocatalytic habitat with molecular parasite exposure (Model 2.1). gan Magnus Pirovino (14845999)

Pynciau:

The alternative model 3.0.1 with reduced catalytic activity and <i>K</i>_<i>M</i> values in μM range. gan Magnus Pirovino (14845999)

Pynciau:

Autocatalytic habitat with molecular parasite exposure (Model 2.1). gan Magnus Pirovino (14845999)

Pynciau:

The reaction scheme for the main model 3. gan Magnus Pirovino (14845999)

Pynciau:

The null catalytic main model 3.1 with <i>K</i>_<i>M</i> values in μM range. gan Magnus Pirovino (14845999)

Pynciau:

S1 Table - gan Magnus Pirovino (14845999)

Pynciau:

Autocatalytic habitat with molecular parasite inflow (Model 2.2). gan Magnus Pirovino (14845999)

Pynciau:

The alternative model 3.0.2 with reduced catalytic activity and <i>K</i>_<i>M</i> values in 0.1 μM range. gan Magnus Pirovino (14845999)

Pynciau:

The reaction schemes for the main models 1 and 2. gan Magnus Pirovino (14845999)

Pynciau:

Synopsis of the main models and of submodels. gan Magnus Pirovino (14845999)

Pynciau:

The null catalytic main model 3.2 and <i>K</i>_<i>M</i> values in 0.1 μM range. gan Magnus Pirovino (14845999)

Pynciau:

Habitat with autocatalytic host cycle (Model 1). gan Magnus Pirovino (14845999)

Pynciau:

Stabilized host-parasite-hyperparasite cycle with <i>K</i>_<i>M</i> in 0.1 μM range. gan Magnus Pirovino (14845999)

Pynciau:

Trialblazers: “Build-a-Trial” workshops for people with psoriatic arthritis gan Caroline Struthers (754411)

“...This was to be followed in June 2024 by an application to the Medical Research Council (MRC) funding stream for a grant in understanding public involvement in non-clinical research.</p><p dir="ltr">In collaboration with the NDORMS’ public-involvement group, Open Arms, and led by clinician researcher Laura Coates, the team developed and ran Build-a-Trial workshops with patients to design this much needed trial from scratch. ...”

Movement distortion in the six conditions. gan Thibault Porssut (12184546)

Pynciau:

Protocol overview. gan Thibault Porssut (12184546)

Pynciau:

The task. gan Thibault Porssut (12184546)

Pynciau:

Results for each experimental case (as numbered in Fig 3 with their respective color). gan Thibault Porssut (12184546)

Pynciau: